|
AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced tumors: Preliminary results from ongoing phase I studies. |
|
|
Employment - BioCytics; Carolina BioOncology Institute |
Leadership - BioCytics; Carolina BioOncology Institute |
Stock and Other Ownership Interests - BioCytics; Bluebird Bio; Carolina BioOncology Institute; Juno Therapeutics; Kite, a Gilead company; Lion Biotechnologies; ZIOPHARM Oncology |
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Curis; Genentech/Roche; TopAlliance BioSciences Inc |
Speakers' Bureau - Bristol-Myers Squibb; Dendreon; Genentech/Roche; Merck |
Research Funding - Abbvie; Alkermes; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Corvus Pharmaceuticals; Curis; EMD Serono; FLX Bio; Genentech/Roche; Incyte; Lilly/ImClone; Macrogenics; Seagen; Tempest Therapeutics; Top Alliance BioScience |
Patents, Royalties, Other Intellectual Property - BioCytics is developing intellectual property for cellular immunotherapy |
Other Relationship - Ongoing discussions with potential future biopharma and biotech for Human Applications Lab sponsored projects |
|
|
|
Consulting or Advisory Role - Astellas Pharma; GlaxoSmithKline; Janssen; Pfizer |
Research Funding - Multiple pharma companies |
Expert Testimony - Janssen |
|
|
Employment - The Angeles Clinic & Research Institute |
|
|
Employment - Connected Medical Solutions (I) |
Leadership - Connected Medical Solutions (I) |
Stock and Other Ownership Interests - Connected Medical Solutions (I) |
Research Funding - Astellas Pharma |
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag |
|
|
Employment - Arcus Biosciences |
Stock and Other Ownership Interests - Arcus Biosciences |
Research Funding - Arcus Biosciences |
|
|
Employment - Arcus Biosciences |
Stock and Other Ownership Interests - Arcus Biosciences |
|
|
Employment - Arcus Biosciences |
Stock and Other Ownership Interests - Arcus Biosciences |
|
|
Employment - Arcus Biosciences |
Leadership - Arcus Biosciences |
Stock and Other Ownership Interests - Arcus Biosciences |
|
|
Employment - Arcus Biosciences |
Leadership - Arcus Biosciences |
Stock and Other Ownership Interests - Arcus Biosciences |
Consulting or Advisory Role - Shasqi Inc. |
Patents, Royalties, Other Intellectual Property - Arcus Biosciences |
|
|
Employment - Arcus Biosciences |
Stock and Other Ownership Interests - Arcus Biosciences |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Arcus Biosciences; Indivumed |
|
|
Employment - Arcus Biosciences |
Stock and Other Ownership Interests - PrimeVax |
|
|
|
Stock and Other Ownership Interests - Novartis |
Consulting or Advisory Role - Bayer |
|
Research Funding - Not to individual (Inst) |